Risk Factors
432 articles
Meet the Researcher: Arnav Mehta, M.D., Ph.D.
Dr. Arnav Mehta combines mathematics and medicine in his search to improve options for gastrointestinal cancer patients. Learn about his groundbreaking work.
When Certain Chemotherapy Drugs Are in Short Supply
It’s been all over the news–some chemotherapy drugs are in short supply. Dr. Allyson Ocean explains a doctor’s options in these situations.
The Whys and Hows of Pancreatic Enzyme Replacement Therapy
Pancreatic enzyme replacement therapy (PERT), is an important part of treatment that is often not properly utilized, but a new tool can help.
Focus on Nutrition with The National Pancreas Foundation
Because they focus on all diseases of the pancreas, the National Pancreas Foundation created a cookbook to guide patients on how to eat.
Why Clinical Trials Should Be a Patient’s Starting Point
Why are clinical trials such an important part of pancreatic cancer treatment? We outline many reasons doctors and patients should look at trials.
Controlling Pain During Pancreatic Cancer Treatment
Dr. Michael Erdek, Jr., a pain management specialist, outlines the methods used to control pain in pancreatic cancer patients.
Identify Your Risk Early
Long-term survivor Scott Nelson was diagnosed with pancreatic cancer, so older brother Steve joined a screening study, which caught his cancer at its earliest stages.
A Second Opinion: Important for Pancreatic Cancer Patients
Dr. Allyson Ocean and Dr. Jordan Winter explain why getting a second opinion can be of great benefit for pancreatic cancer patients.
Unraveling the Web for Reliable Pancreatic Cancer Information
Dr. Mark Lewis and journalist Steve Doig explain how to judge whether the information about pancreatic cancer on the internet is from a reliable source.
Drafting Your Health Care Team
If you have pancreatic cancer, a treatment team of experts from across the medical profession will make sure you get the best care.
My BRCA2 Mutation Turned Out to Be Both the Curse and the Cure
Sharon Seibel knew she had the BRCA2 mutation but was unaware of the link to pancreatic cancer. Her chemotherapy was one for BRCA carriers.
Genomic Testing of Pancreatic Tumor Leads to an Important Discovery
Connie Waxman learned the value of palliative care after chemotherapy, radiation, and a pancreatectomy for pancreatic cancer; then she had genomic testing.
Maintenance Chemotherapy Trial for Pancreatic Cancer Patients with the BRCA Mutation
A clinical trial for patients with BRCA mutations uses a PARP inhibitor as part of the maintenance chemotherapy experimental treatment.
Younger Brother’s Pancreatic Cancer Leads to Regular Screening for his Oldest Brother
When Scott Nelson was diagnosed with pancreatic cancer, oldest brother Steve began regular screening, which lead to his early diagnosis.
Tumor RNA Testing Leads to Treatment with a New Drug
When treatment stopped working for Adam Deal, genetic testing of his tumor RNA found a mutation that made him eligible to try a new drug.